Helena W. Rodbard
About
Helena W. Rodbard is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Surgery.
According to data from OpenAlex, Helena W. Rodbard has authored 100 papers receiving a total of 5.9k indexed citations (citations by other indexed papers that have themselves been cited), including 79 papers in Endocrinology, Diabetes and Metabolism, 34 papers in Molecular Biology and 25 papers in Surgery. Recurrent topics in Helena W. Rodbard's work include Diabetes Treatment and Management (63 papers), Diabetes Management and Research (55 papers) and Metabolism, Diabetes, and Cancer (31 papers). Helena W. Rodbard is often cited by papers focused on Diabetes Treatment and Management (63 papers), Diabetes Management and Research (55 papers) and Metabolism, Diabetes, and Cancer (31 papers). Helena W. Rodbard collaborates with scholars based in United States, Denmark and United Kingdom. Helena W. Rodbard's co-authors include Yehuda Handelsman, Paul S. Jellinger, John B. Buse, Donald A. Bergman, John A. Seibel, Harold Bays, J. Michael González-Campoy, Alan J. Garber, Alan B. Schorr and Bertrand Cariou and has published in prestigious journals such as JAMA, SHILAP Revista de lepidopterología and The Journal of Clinical Endocrinology & Metabolism.
In The Last Decade
Helena W. Rodbard
98 papers receiving 5.5k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Helena W. Rodbard United States | 37 | 4.4k | 1.8k | 1.5k | 667 | 612 | 100 | 5.9k | ||
| Paul S. Jellinger United States | 23 | 3.8k 0.9× | 1.3k 0.7× | 1.7k 1.1× | 527 0.8× | 583 1.0× | 38 | 5.4k | ||
| Maria Ida Maiorino Italy | 48 | 4.0k 0.9× | 1.4k 0.8× | 1.1k 0.7× | 1.4k 2.1× | 475 0.8× | 186 | 7.0k | ||
| Michael A. Bush United States | 18 | 2.3k 0.5× | 824 0.5× | 1.1k 0.7× | 346 0.5× | 405 0.7× | 32 | 4.6k | ||
| Daniel Einhorn United States | 27 | 5.8k 1.3× | 2.0k 1.1× | 1.6k 1.1× | 891 1.3× | 738 1.2× | 43 | 7.4k | ||
| Tsvetalina Tankova Bulgaria | 31 | 3.7k 0.9× | 1.5k 0.8× | 1.1k 0.7× | 1.0k 1.5× | 680 1.1× | 123 | 5.4k | ||
| Mikkel Christensen Denmark | 39 | 3.9k 0.9× | 1.8k 1.0× | 2.1k 1.3× | 915 1.4× | 809 1.3× | 163 | 5.6k | ||
| Vanita R. Aroda United States | 49 | 7.3k 1.7× | 3.2k 1.8× | 2.1k 1.4× | 1.6k 2.4× | 1.4k 2.3× | 166 | 10.2k | ||
| W. Timothy Garvey United States | 33 | 3.1k 0.7× | 1.8k 1.0× | 1.4k 0.9× | 1.9k 2.8× | 694 1.1× | 68 | 6.3k | ||
| Judith Fradkin United States | 25 | 5.3k 1.2× | 2.3k 1.3× | 1.4k 0.9× | 852 1.3× | 488 0.8× | 46 | 7.5k | ||
| Jorge Luiz Gross Brazil | 51 | 5.8k 1.3× | 2.3k 1.3× | 2.3k 1.5× | 1.5k 2.3× | 796 1.3× | 234 | 10.5k |
Countries citing papers authored by Helena W. Rodbard
Since
Specialization
Citations
This map shows the geographic impact of Helena W. Rodbard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helena W. Rodbard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helena W. Rodbard more than expected).
Fields of papers citing papers by Helena W. Rodbard
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Helena W. Rodbard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helena W. Rodbard. The network helps show where Helena W. Rodbard may publish in the future.
Co-authorship network of co-authors of Helena W. Rodbard
This figure shows the co-authorship network connecting the top 25 collaborators of Helena W. Rodbard. A scholar is included among the top collaborators of Helena W. Rodbard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Helena W. Rodbard. Helena W. Rodbard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Giorgino, Francesco, Tadej Battelino, Richard M. Bergenstal, et al.. (2023). The Role of Ultra-Rapid-Acting Insulin Analogs in Diabetes: An Expert Consensus. Journal of Diabetes Science and Technology. 19(2). 452–469.
2.
Ji, Linong, Andrew Ahmann, Bo Åhrén, et al.. (2023). Proportion of participants with type 2 diabetes achieving a metabolic composite endpoint with once‐weekly semaglutide treatment versus comparators: Post hoc pooled analysis from SUSTAIN 1‐5, 7‐10 and SUSTAIN China. Diabetes Obesity and Metabolism. 26(1). 233–241.
3.
Blüher, Matthias, Antonio Ceriello, Melanie J. Davies, et al.. (2022). Managing weight and glycaemic targets in people with type 2 diabetes—How far have we come?. Endocrinology Diabetes & Metabolism. 5(3). e00330–e00330.
4.
Marx, Nikolaus, Lars Rydén, Frank C. Brosius, et al.. (2020). Proceedings of the Guideline Workshop 2019: Strategies for the Optimization of Guideline Processes in Diabetes, Cardiovascular Diseases, and Kidney Diseases. Diabetes Technology & Therapeutics. 22(7). 546–552.
5.
Marx, Nikolaus, Lars Rydén, Frank C. Brosius, et al.. (2020). Proceedings of the Guideline Workshop 2019 – Strategies for the optimization of guideline processes in diabetes, cardiovascular diseases and kidney diseases. Diabetes Research and Clinical Practice. 162. 108092–108092.
6.
Danne, Thomas, Jeremy Pettus, Andrea Giaccari, et al.. (2019). Sotagliflozin Added to Optimized Insulin Therapy Leads to Lower Rates of Clinically Relevant Hypoglycemic Events at Any HbA1c at 52 Weeks in Adults with Type 1 Diabetes. Diabetes Technology & Therapeutics. 21(9). 471–477.
7.
Bowering, Keith, Helena W. Rodbard, David Russell‐Jones, et al.. (2018). Investigating the Association Between Baseline Characteristics (HbA1c and Body Mass Index) and Clinical Outcomes of Fast-Acting Insulin Aspart in People with Diabetes: A Post Hoc Analysis. Diabetes Therapy. 10(1). 177–188.
8.
Rodbard, Helena W., Ildiko Lingvay, John H. Reed, et al.. (2016). Efficacy and Safety of Semaglutide Once-Weekly vs. Placebo as Add-on to Basal Insulin Alone or in Combination with Metformin in Subjects with Type 2 Diabetes (SUSTAIN 5). Canadian Journal of Diabetes. 40(5). S41–S42.
9.
Rodbard, Helena W., et al.. (2014). Management of Type 2 Diabetes – Methods for Addition of Prandial to Basal Insulin. touchREVIEWS in Endocrinology. 10(2). 124–124.
10.
Rodbard, Helena W., et al.. (2014). PO343 TREATMENT INTENSIFICATION WITH IDEGASP BID VS IDEG OD PLUS IASP IN INSULIN-TREATED PATIENTS WITH TYPE 2 DIABETES: A RANDOMIZED, CONTROLLED PHASE 3 TRIAL. Diabetes Research and Clinical Practice. 106. S222–S223.
11.
Rodbard, Helena W., Stephen Gough, Wendy Lane, et al.. (2013). Reduced Risk of Hypoglycemia with Insulin Degludec Versus Insulin Glargine in Patients with Type 2 Diabetes Requiring High Doses of Basal Insulin: A Meta-Analysis of 5 Randomized Begin Trials. Endocrine Practice. 20(4). 285–292.
12.
Rodbard, Helena W., Bernard Zinman, Bertrand Cariou, et al.. (2012). Reduced nocturnal hypoglycaemia with insulin degludec as compared to insulin glargine: results of a 2-year randomised trial in type 2 diabetes. Diabetologia. 55.
13.
Rodbard, Helena W., Andrew Green, Kathleen M. Fox, & Susan Grandy. (2010). Impact of type 2 diabetes mellitus on prescription medication burden and out-of-pocket healthcare expenses. Diabetes Research and Clinical Practice. 87(3). 360–365.
14.
Mechanick, Jeffrey I., Pauline M. Camacho, Rhoda H. Cobin, et al.. (2010). American Association Of Clinical Endocrinologists Protocol For Standardized Production Of Clinical Practice Guidelines—2010 Update. Endocrine Practice. 16(2). 270–283.
15.
Lewis, Sandra J., et al.. (2008). Self-reported prevalence and awareness of metabolic syndrome: findings from SHIELD. International Journal of Clinical Practice. 62(8). 1168–1176.
16.
Bays, Harold, J. Michael González-Campoy, Robert R. Henry, et al.. (2008). Is adiposopathy (sick fat) an endocrine disease?. International Journal of Clinical Practice. 62(10). 1474–1483.
17.
Kannel, William B., Angel López‐Candales, Leo S. Morales, et al.. (2007). Avoiding the looming Latino/Hispanic cardiovascular health crisis: a call to action.. PubMed. 17(3). 568–73.
18.
Gharib, Hossein, David M. Cook, Paul Saenger, et al.. (2003). American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for Growth Hormone Use in Adults and Children—2003 Update. Endocrine Practice. 9(1). 64–76.
19.
Rizza, Robert A., Robert A. Vigersky, Helena W. Rodbard, et al.. (2003). A Model to Determine Workforce Needs for Endocrinologists in the United States Until 2020. Endocrine Practice. 9(3). 210–219.
20.
Petak, Steven M., Howard R. Nankin, Richard F. Spark, et al.. (2002). American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the Evaluation and Treatment of Hypogonadism in Adult Male Patients—2002 Update. Endocrine Practice. 8(6). 439–456.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Paul S. Jellinger Breakdown of academic impact, for papers by Maria Ida Maiorino Breakdown of academic impact, for papers by Michael A. Bush Breakdown of academic impact, for papers by Daniel Einhorn Breakdown of academic impact, for papers by Tsvetalina Tankova Breakdown of academic impact, for papers by Mikkel Christensen Breakdown of academic impact, for papers by Vanita R. Aroda Breakdown of academic impact, for papers by W. Timothy Garvey Breakdown of academic impact, for papers by Judith Fradkin Breakdown of academic impact, for papers by Jorge Luiz Gross